Is Adjuvant Therapy for Older Patients with Node (+) Early Breast Cancercost-effective?* Arash NaeimEmmett B. Keeler Report Pages: 95 - 103
Polymorphisms of the BRCA2 and RAD51 Genes in Breast Cancer Tomasz SliwinskiRenata KrupaJanusz Blasiak Report Pages: 105 - 109
High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families Jacek GronwaldPavel ElsakovJan LubiĆski Report Pages: 111 - 113
Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population Jeffrey A. TiceSteven R. CummingsKarla Kerlikowske Epidemiology Pages: 115 - 122
A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer Louisa G. GordonPaul ScuffhamBeth Newman Report Pages: 123 - 133
Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study Mala BahlMarguerite EnnisPamela J. Goodwin Report Pages: 135 - 144
Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer Paula MaguireSara MargolinAnnika Lindblom Report Pages: 145 - 152
How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide Andrew McKayWanda MartinSteven Latosinsky Report Pages: 153 - 159
Anti-estrogenic Effects of Conjugated Linoleic Acid through Modulation of Estrogen Receptor Phosphorylation Jingbo LiuNeil Sidell Report Pages: 161 - 169
Progesterone Pre-treatment Potentiates EGF Pathway Signaling in The Breast Cancer Cell Line ZR-75* A. CarvajalN. EspinozaG. I. Owen Report Pages: 171 - 183
Tissue Inhibitor of Metalloproteinases-1 Stimulates Gene Expression in MDA-MB-435 Human Breast Cancer Cells by Means of its Ability to Inhibit Metalloproteinases Joseph F. PorterShashi SharmaDavid T. Denhardt Report Pages: 185 - 193